Form D · Pharmaceuticals

AyuVis Research, Inc.

Fort Worth, TX · CIK 0001739776

Offering snapshot reported Oct 16, 2019 · SEC filing

Reported sold: $745K
Investors reported: 17
Minimum accepted: $0
First sale: Apr 19, 2019

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 16, 2019	Amendment	$745,000	$0vs Oct 11, 2019	17	SEC filing
Oct 11, 2019	Initial	$745,000	No comparison	17	SEC filing
Apr 4, 2019	Amendment	$1,300,000	$1,080,000vs May 7, 2018	26	SEC filing
May 7, 2018	Initial	$220,000	No comparison	10	SEC filing

Offering details

Securities: Debt, Option to acquire
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-350883

Source: Form D, filed Oct 16, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Gagan Acharya	Director
Suchismita Acharya	Director, Executive
Beamon Agarwal	Executive
Russell Bromley	Executive
William Dennis Dean	Executive
Dwight Horton	Executive
Stella M Robertson	Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

1120 South Freeway #123 E
Fort Worth, TX, 76104